physIQ licenses virtual trial tech to Janssen in multi-year deal
pharmaphorum
APRIL 22, 2021
Biosensor firm physIQ has licensed its technology to Johnson & Johnson’s Janssen pharma unit in a multi-year deal, to investigate use of wearable sensors in virtual clinical trials. The poll of 114 triallists by clinical data specialist ERT found 82% of them found organisations aery using “virtual trial” approaches.
Let's personalize your content